Cargando…
Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases
BACKGROUND: Diffuse midline glioma (DMG) which occurs in midline structures and characterized by harboring K27M mutation in genes encoding the histone 3 protein is classified as World Health Organization (WHO) grade IV regardless of histological findings and has a poor prognosis. Nevertheless, becau...
Autores principales: | Jang, Sun Woo, Song, Sang Woo, Kim, Young-Hoon, Cho, Young Hyun, Hong, Seok Ho, Kim, Jeong Hoon, Ra, Young-Shin, Chong, Sangjoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650120/ https://www.ncbi.nlm.nih.gov/pubmed/36347640 http://dx.doi.org/10.14791/btrt.2022.0035 |
Ejemplares similares
-
The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
por: Yoon, Hong In, et al.
Publicado: (2021) -
A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
por: Kim, Sung Kwon, et al.
Publicado: (2020) -
Treatment Outcome of Hydrocephalus Associated with Vestibular Schwannoma
por: Shin, Dong-Won, et al.
Publicado: (2021) -
CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
por: Barron, Tara, et al.
Publicado: (2023) -
Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma
por: Park, Changhee, et al.
Publicado: (2021)